Emergency Neurological Life Support: Pharmacotherapy

Area of Science:

• Neurocritical Care
• Pharmacology
• Emergency Medicine

Background:

• Effective medication management is crucial for optimizing patient outcomes in Emergency Neurological Life Support (ENLS).
• Individual patient factors such as organ function, allergies, and pathophysiologic changes in critical illness and aging significantly influence drug selection.
• A comprehensive understanding of drug properties is essential for safe and effective neurocritical care.

Purpose of the Study:

• To provide essential drug information for practitioners managing acutely ill neurocritical care patients.
• To highlight key pharmacokinetic and pharmacodynamic characteristics, advantages, disadvantages, and clinical pearls of critical ENLS medications.
• To guide the optimization of pharmacotherapy in the context of Emergency Neurological Life Support.

Main Methods:

• Review of critical medications used in Emergency Neurological Life Support.
• Analysis of pharmacokinetic and pharmacodynamic properties of selected drug classes.
• Discussion of clinical considerations, including patient-specific factors and drug interactions.

Main Results:

• Identified critical medication categories for ENLS: hyperosmolar therapy, anticonvulsants, antithrombotics, anticoagulant reversal/hemostatic agents, anti-shivering agents, neuromuscular blockers, antihypertensives, sedatives, vasopressors/inotropes, and antimicrobials.
• Detailed the advantages, disadvantages, and clinical pearls for each medication class.
• Emphasized the importance of considering organ function, allergies, adverse effects, and drug interactions.

Conclusions:

• Appropriate selection and use of medications are paramount in Emergency Neurological Life Support.
• Understanding drug characteristics and patient-specific factors optimizes pharmacotherapy in neurocritical care.
• This review serves as a resource for evidence-based medication management in critically ill neurological patients.